# Single Ascending Doses Study of KLS-2031 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy

> **NCT04238793** · PHASE1,PHASE2 · COMPLETED · sponsor: **Kolon Life Science** · enrollment: 18 (actual)

## Conditions studied

- Neuropathic Pain From Lumbosacral Radiculopathy

## Interventions

- **DRUG:** KLS-2031
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04238793
- **Lead sponsor:** Kolon Life Science
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-16
- **Primary completion:** 2023-10-18
- **Final completion:** 2023-10-18
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2024-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04238793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04238793, "Single Ascending Doses Study of KLS-2031 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04238793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*